Statins and the risk of pancreatic cancer in Type 2 diabetic patients - A population-based cohort study

International Journal of Cancer

Volumn 138, Issue 3, 2016, Pages 594-603

  Chen, Mei Jyh ^a,b   Tsan, Yu Tse ^c,d   Liou, Jyh Ming ^b   Lee, Yi Chia ^b   Wu, Ming Shiang ^b   Chiu, Han Mo ^b   Wang, Hsiu Po ^b   Chen, Pau Chung ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Chemoprevention; Diabetes mellitus; Pancreatic cancer; Statins

Indexed keywords

GLITAZONE DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; SULFONYLUREA;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; ICD-9-CM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NATIONAL HEALTH INSURANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS CANCER; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; URBANIZATION; WORLD HEALTH ORGANIZATION; YOUNG ADULT; ADOLESCENT; COMPLICATION; DOSE RESPONSE; PANCREATIC NEOPLASMS; PROPORTIONAL HAZARDS MODEL; RISK;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MIDDLE AGED; PANCREATIC NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK; YOUNG ADULT;

EID: 84955638847     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29813     Document Type: Article

References (39)

1. Raimondi S, Maisonneuve P, Lowenfels AB., Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol 2009; 6: 699-708.
2. Vincent A, Herman J, Schulick R, et al., Pancreatic cancer. Lancet 2011; 378: 607-20.
3. Hassan MM, Bondy ML, Wolff RA, et al., Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol 2007; 102: 2696-707.
4. Magruder JT, Elahi D, Andersen DK., Diabetes and pancreatic cancer: chicken or egg? Pancreas 2011; 40: 339-51.
5. Rosato V, Tavani A, Bosetti C, et al., Metabolic syndrome and pancreatic cancer risk: a case-control study in Italy and meta-analysis. Metabolism 2011; 60: 1372-8.
6. Chan KK, Oza AM, Siu LL., The statins as anticancer agents. Clinical Cancer Res 2003; 9: 10-9.
7. Wong WW, Dimitroulakos J, Minden MD, et al., HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia 2002; 16: 508-19.
8. Mistafa O, Stenius U., Statins inhibit Akt/PKB signaling via P2X7 receptor in pancreatic cancer cells. Biochem Pharmacol 2009; 78: 1115-26.
9. Khurana V, Sheth A, Caldito G, et al., Statins reduce the risk of pancreatic cancer in humans: a case-control study of half a million veterans. Pancreas 2007; 34: 260-5.
10. Bonovas S, Filioussi K, Sitaras NM., Statins are not associated with a reduced risk of pancreatic cancer at the population level, when taken at low doses for managing hypercholesterolemia: evidence from a meta-analysis of 12 studies. Am J Gastroenterol 2008; 103: 2646-51.
11. Cui X, Xie Y, Chen M, et al., Statin use and risk of pancreatic cancer: a meta-analysis. Cancer Causes Control 2012; 23: 1099-111.
12. Carey FJ, Little MW, Pugh TF, et al., The differential effects of statins on the risk of developing pancreatic cancer: a case-control study in two centres in the United Kingdom. Dig Dis Sci 2013; 58: 3308-12.
13. Walker EJ, Ko AH, Holly EA, et al., Statin use and risk of pancreatic cancer: Results from a large, clinic-based case-control study. Cancer 2015; 121: 1287-94.
14. Isomaa B, Almgren P, Tuomi T, et al., Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-9.
15. Kearney PM, Blackwell L, Collins R, et al., Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008; 371: 117-25.
16. Ryden L, Standl E, Bartnik M, et al., The task force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007; 28: 88-136.
17. National Health Insurance Research Institute. National Health Insurance Research Database. Available at: http://nhird.nhri.org.tw/en/, accessed on July 1, 2014.
18. Tsan YT, Lee CH, Ho WC, et al., Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection. J Clin Oncol 2013; 31: 1514-21.
19. Wu CY, Chen YJ, Ho HJ, et al., Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection. J Am Med Assoc 2012; 308: 1906-14.
20. Bilimoria KY, Bentrem DJ, Ko CY, et al., Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database. Cancer 2007; 110: 738-44.
21. WHO Collaborating Centre for Drug Statistics Methodology. Definition and general considerations. Available at: http://www.whocc.no/ddd/definition-and-general-considera/, accessed on July 1, 2014.
22. Gullo L, Pezzilli R, Morselli-Labate AM., Italian Pancreatic Cancer Study G. Diabetes and the risk of pancreatic cancer. N Engl J Med 1994; 331: 81-4.
23. Pelaez-Luna M, Takahashi N, Fletcher JG, et al., Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis. Am J Gastroenterol 2007; 102: 2157-63.
24. Delgado-Rodriguez M, Llorca J., Bias. J Epidemiol Commun Health 2004; 58: 635-41.
25. Chiu HF, Chang CC, Ho SC, et al., Statin use and the risk of pancreatic cancer: a population-based case-control study. Pancreas 2011; 40: 669-72.
26. Nakai Y, Isayama H, Sasaki T, et al., Clinical outcomes of chemotherapy for diabetic and nondiabetic patients with pancreatic cancer: better prognosis with statin use in diabetic patients. Pancreas 2013; 42: 202-8.
27. National Health Insurance Administration Ministry of Health and Welfare. Drugs used for dyslipidemia. Available at: http://www.nhi.gov.tw/webdata/webdata.aspx?menu=21&menu-id=713&webdata-id=2919, accessed on July 1, 2014.
28. Khurana V, Bejjanki HR, Caldito G, et al., Statins reduce the risk of lung cancer in humans: a large case-control study of US veterans. Chest 2007; 131: 1282-8.
29. El-Serag HB, Johnson ML, Hachem C, et al., Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes. Gastroenterology 2009; 136: 1601-8.
30. Hachem C, Morgan R, Johnson M, et al., Statins and the risk of colorectal carcinoma: a nested case-control study in veterans with diabetes. Am J Gastroenterol 2009; 104: 1241-8.
31. Lee J, Lee SH, Hur KY, et al., Statins and the risk of gastric cancer in diabetes patients. BMC Cancer 2012; 12: 596
32. Vigneri P, Frasca F, Sciacca L, et al., Diabetes and cancer. Endocr Relat Cancer 2009; 16: 23. 1
33. Yang X, Zhao H, Sui Y, et al., Additive interaction between the renin-angiotensin system and lipid metabolism for cancer in type 2 diabetes. Diabetes 2009; 58: 1518-25.
34. Blanco-Colio LM, Tunon J, Martin-Ventura JL, et al., Anti-inflammatory and immunomodulatory effects of statins. Kidney Int 2003; 63: 12-23.
35. Bu DX, Griffin G, Lichtman AH., Mechanisms for the anti-inflammatory effects of statins. Curr Opin Lipidol 2011; 22: 165-70.
36. Yang X, So WY, Ma RC, et al., Low LDL cholesterol, albuminuria, and statins for the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry. Diabetes Care 2009; 32: 1826-32.
37. Yang X, Ma RC, So WY., Low triglyceride and nonuse of statins is associated with cancer in type 2 diabetes mellitus: the Hong Kong Diabetes Registry. Cancer 2011; 117: 862-71.
38. Gallagher EJ, LeRoith D., Minireview: IGF, insulin, and cancer. Endocrinology 2011; 152: 2546-51.
39. Bergmann U, Funatomi H, Yokoyama M, et al., Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res 1995; 55: 2007-11.